120 related articles for article (PubMed ID: 9029140)
1. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia.
van der Poll T; Jansen PM; Montegut WJ; Braxton CC; Calvano SE; Stackpole SA; Smith SR; Swanson SW; Hack CE; Lowry SF; Moldawer LL
J Immunol; 1997 Feb; 158(4):1971-5. PubMed ID: 9029140
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
Renckens R; Weijer S; de Vos AF; Pater JM; Meijers JC; Hack CE; Levi M; van der Poll T
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):483-8. PubMed ID: 14739127
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees.
Lauw FN; Dekkers PE; te Velde AA; Speelman P; Levi M; Kurimoto M; Hack CE; van Deventer SJ; van der Poll T
J Infect Dis; 1999 Mar; 179(3):646-52. PubMed ID: 9952371
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte, plasma, and organ-associated cytokine profiles in an animal model of acute inflammation.
Ebdrup L; Krog J; Granfeldt A; Larsen PØ; Vestergaard C; Hokland M; Tønnesen E
APMIS; 2008 May; 116(5):352-60. PubMed ID: 18452425
[TBL] [Abstract][Full Text] [Related]
5. Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
Verbon A; Meijers JC; Spek CA; Hack CE; Pribble JP; Turner T; Dekkers PE; Axtelle T; Levi M; van Deventer SJ; Reitsma PH; van der Poll T
J Infect Dis; 2003 Jan; 187(1):55-61. PubMed ID: 12508146
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration.
Pajkrt D; Camoglio L; Tiel-van Buul MC; de Bruin K; Cutler DL; Affrime MB; Rikken G; van der Poll T; ten Cate JW; van Deventer SJ
J Immunol; 1997 Apr; 158(8):3971-7. PubMed ID: 9103468
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia.
Pajkrt D; van der Poll T; Levi M; Cutler DL; Affrime MB; van den Ende A; ten Cate JW; van Deventer SJ
Blood; 1997 Apr; 89(8):2701-5. PubMed ID: 9108387
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
[TBL] [Abstract][Full Text] [Related]
10. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
[TBL] [Abstract][Full Text] [Related]
11. Dobutamine does not influence inflammatory pathways during human endotoxemia.
Lemaire LC; de Kruif MD; Giebelen IA; Levi M; van der Poll T; Heesen M
Crit Care Med; 2006 May; 34(5):1365-71. PubMed ID: 16540959
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
[TBL] [Abstract][Full Text] [Related]
13. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans.
van der Poll T; Coyle SM; Levi M; Jansen PM; Dentener M; Barbosa K; Buurman WA; Hack CE; ten Cate JW; Agosti JM; Lowry SF
Blood; 1997 May; 89(10):3727-34. PubMed ID: 9160678
[TBL] [Abstract][Full Text] [Related]
14. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production.
Muchamuel T; Menon S; Pisacane P; Howard MC; Cockayne DA
J Immunol; 1997 Mar; 158(6):2898-903. PubMed ID: 9058827
[TBL] [Abstract][Full Text] [Related]
15. In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons.
Mestries JC; Kruithof EK; Gascon MP; Herodin F; Agay D; Ythier A
Eur Cytokine Netw; 1994; 5(3):275-81. PubMed ID: 7948765
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia.
Xing Z; Ohkawara Y; Jordana M; Graham FL; Gauldie J
Gene Ther; 1997 Feb; 4(2):140-9. PubMed ID: 9081704
[TBL] [Abstract][Full Text] [Related]
17. Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats.
van Westerloo DJ; Giebelen IA; Meijers JC; Daalhuisen J; de Vos AF; Levi M; van der Poll T
J Thromb Haemost; 2006 Sep; 4(9):1997-2002. PubMed ID: 16805873
[TBL] [Abstract][Full Text] [Related]
18. Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia.
de Kruif MD; Lemaire LC; Giebelen IA; van Zoelen MA; Pater JM; van den Pangaart PS; Groot AP; de Vos AF; Elliott PJ; Meijers JC; Levi M; van der Poll T
J Immunol; 2007 Feb; 178(3):1845-51. PubMed ID: 17237435
[TBL] [Abstract][Full Text] [Related]
19. Isoflurane inhalation after induction of endotoxemia in rats attenuates the systemic cytokine response.
Flondor M; Hofstetter C; Boost KA; Betz C; Homann M; Zwissler B
Eur Surg Res; 2008; 40(1):1-6. PubMed ID: 17717418
[TBL] [Abstract][Full Text] [Related]
20. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
